Although the policy speaks of encouraging open source drug discovery (OSDD), it is well known that the OSDD programme is no longer being pursued by CSIR. - See more at: http://www.epw.in/journal/2016/24/commentary/wrong-incentive.html#sthash.krH3nH5S.dpuf
http://www.epw.in/journal/2016/24/commentary/wrong-incentive.html -- JALEEL